← Back to patent-cliff list
SNB-011
Tier C — Watch / tradeSNB-011
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：CMA1, 3CLp, DAO, Serine protease, Cytokines
Brand：Pentarlandir UPPTA, Airnecflu
Indications (approved)：COVID-19
Regional status
US
No progress
2021-08-24
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SNB-011?
Approved indications include: COVID-19.
When does the SNB-011 patent expire?
No public expiry year is available for SNB-011 yet; this page updates once verified.
How do I get a quote for SNB-011 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21